We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues ‘Small Entity’ Guidance for Importing Prescription Drugs From Canada
FDA Issues ‘Small Entity’ Guidance for Importing Prescription Drugs From Canada
To help small entities follow its 2020 final rule on importing prescription drugs from Canada, the FDA released a compliance guide yesterday explaining that U.S. importation programs must show “significant cost reductions” of the products to American consumers.